Latest / Stock Movers / Unilever Down, Galderma Rises, Monte Paschi Up
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg data.
- 0:16Speaker 3: Now, let's look at some of the stocks on the
- 0:18Speaker 3: move today here in Europe. I'm Caroline Hepget and I'm
- 0:20Speaker 3: joined by Blueberg reporter Cloim mala Cloy. Good morning. So
- 0:24Speaker 3: it's been cult outside, but it might just be the
- 0:28Speaker 3: right time for ice cream still. Maybe is it Unilever's
- 0:32Speaker 3: Magnum deal.
- 0:33Speaker 1: Yeah, absolutely so.
- 0:35Speaker 4: Magnum ice Cream Company has started trading today in London,
- 0:38Speaker 4: Amsterdam and a little bit later in New York. So
- 0:41Speaker 4: the spin off of the ice cream unit for the
- 0:43Speaker 4: Unilever is now completed. It happened a month later than
- 0:46Speaker 4: originally planned because it was pushed back because of the
- 0:49Speaker 4: US government has shut down.
- 0:51Speaker 1: So now the focus is really going to be.
- 0:53Speaker 4: On Unilever's prospects as a standalone company, and given how
- 0:57Speaker 4: shares fell today for unile but perhaps the investor enthusiasm
- 1:02Speaker 4: isn't really there at the moment. And then for Magnum itself,
- 1:05Speaker 4: for this new company, they are also challenges of course
- 1:08Speaker 4: as well, So there's obviously a growing number of really
- 1:11Speaker 4: health conscious consumers, maybe people that don't necessarily want to
- 1:14Speaker 4: have ice cream. There's obviously, of course weight loss drugs
- 1:18Speaker 4: which limit appetite. And then it's also quite a capital
- 1:21Speaker 4: intensive business. So this is a part of Unilever that
- 1:24Speaker 4: was dealing with quite high production costs, quite high storage costs,
- 1:28Speaker 4: and that really weighed on margins. That's part of the
- 1:30Speaker 4: reason why there was a push to demerge that company.
- 1:34Speaker 1: But now perhaps Magnum can refocus.
- 1:37Speaker 4: The management team is quite well regarded by analysts, and
- 1:41Speaker 4: analysts are saying that the company can now really reinvest
- 1:44Speaker 4: in growth and really refocus after it really was all
- 1:48Speaker 4: about returns and cash under Unilever.
- 1:51Speaker 1: So we'll see how that goes.
- 1:52Speaker 4: But yeah, it's an interesting time of year to be
- 1:55Speaker 4: to be listing an ice cream business. Yeah.
- 1:56Speaker 1: Absolutely.
- 1:57Speaker 3: Apparently in the UK, in the factory they make about
- 2:00Speaker 3: six hundred million ice creams a year, the vast majority
- 2:03Speaker 3: for people here in the UK. So yes, we're still
- 2:05Speaker 3: eating the odd Madner, I would argue.
- 2:08Speaker 1: I am, and I am right.
- 2:10Speaker 3: Secondly, Skins Care in the Spotlight with Galderma, I read
- 2:16Speaker 3: that this morning. I can't say I know that name.
- 2:19Speaker 3: What's the story there?
- 2:20Speaker 4: So Loreal has double this steak in Galderma this morning.
- 2:23Speaker 4: So gal Demo is a company that is in skincareess
- 2:26Speaker 4: but is known primarily for making injectibles so botox, fillers,
- 2:29Speaker 4: et cetera. But then just in the kind of wider
- 2:32Speaker 4: dermatology space. So now the steak from Loreal is now
- 2:35Speaker 4: twenty percent, So that is doubled from the ten percent
- 2:38Speaker 4: that Loreal took last year. So it's really reinforcing that
- 2:42Speaker 4: investment in dermatology and trying to gain maybe a stronger
- 2:45Speaker 4: foothold as well in that injectibles market. And Liz have
- 2:48Speaker 4: said that the investment makes a lot of strategic sense.
- 2:51Speaker 4: You've got one company that has got their leadership in dermatology,
- 2:54Speaker 4: and then the other kind of brings that expertise as
- 2:57Speaker 4: a leading beauty company. Of course, Loreal being such a
- 2:59Speaker 4: big name, Galdamahs were up on the back of that,
- 3:03Speaker 4: but Lories are actually down, so it might be because
- 3:06Speaker 4: of Laura has been making so many deals recently. I
- 3:08Speaker 4: recently bought a South Korean brand called dr G. It
- 3:12Speaker 4: took a majority stake in a UK skincare brand called Medicaid,
- 3:16Speaker 4: so perhaps one too many deal for investors at this morning,
- 3:18Speaker 4: but for Galdermo was definitely seen as a positive.
- 3:22Speaker 3: Interesting, Maybe is it me or do I relate?
- 3:25Speaker 1: Is it may just be me?
- 3:27Speaker 3: Kate Winslet was talking about injectables and beauty just over
- 3:30Speaker 3: the weekend.
- 3:31Speaker 1: I got picked up very widely. I saw did you
- 3:33Speaker 1: see that?
- 3:34Speaker 3: Yeah, obviously very beautiful actress saying you know, we should
- 3:39Speaker 3: have the natural look was which I thought was interesting. Now,
- 3:45Speaker 3: in terms of Monte Pasci, Monte Tepasci reaffirming confidence in
- 3:50Speaker 3: its CEO. What about this bank?
- 3:52Speaker 4: Yeah, so it reaffirmed that their confidence kind of reaffirmed
- 3:56Speaker 4: its support for the CEO's currently caught in a probe
- 3:59Speaker 4: into a takeover of Medio Banker. So Luis gilovaglio Is,
- 4:04Speaker 4: who's the CEO, is currently being investigated by prosecutors for
- 4:09Speaker 4: allegedly coordinating this Medio Banker acquisition with two big investors.
- 4:14Speaker 4: So that probe has really weighed on the shares, but
- 4:16Speaker 4: there seems to be maybe some relief from Montepesci. The
- 4:19Speaker 4: market regulator in Italy has ruled out the existence of
- 4:22Speaker 4: an undisclosed investor pact that involves PASKI and some of
- 4:26Speaker 4: its shareholders in that bid for Medio Banker, So that
- 4:30Speaker 4: development and then also the bank reaffirming that support and
- 4:33Speaker 4: that confidence in the CEO has been supporting that share
- 4:36Speaker 4: price today. So quite a good day for Pesci after
- 4:39Speaker 4: a lot of weakness over the last couple of weeks.
- 4:42Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 4:46Speaker 2: us throughout the day for the latest roundup of companies
- 4:49Speaker 2: making news on Wall Street and for the latest market
- 4:52Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:57Speaker 2: Bloomberg dot com and on Applecarplay. And Andrew writ Auto
- 5:00Speaker 2: with the Bloomberg Business app.
- 5:06Speaker 3: Mm hmm